Fuller R W
Annu Rev Pharmacol Toxicol. 1982;22:31-55. doi: 10.1146/annurev.pa.22.040182.000335.
Neurons that contain PNMT, the epinephrine-forming enzyme, have their cell bodies in brain stem regions in rat brain and send projections mainly into other brain stem areas, hypothalamus, and spinal cord. These neurons can be affected pharmacologically by various kinds of drugs. Epinephrine neuronal systems might play a part in some pharmacologic actions of MAO inhibitors and uptake inhibitors as well as alpha and beta agonists and antagonists. PNMT inhibitors currently represent the only means of modifying epinephrine neurons pharmacologically without also altering norepinephrine or dopamine neurons in brain. The continued study of drugs affecting epinephrine neurons should be useful in elucidating functions of these neurons. Drugs that affect epinephrine neurons may be of use in the treatment of hypertension, psychiatric disorders, neuroendocrine dysfunction, and possibly other diseases.
含有去甲肾上腺素甲基转移酶(PNMT,一种形成肾上腺素的酶)的神经元,其细胞体位于大鼠脑的脑干区域,并主要向其他脑干区域、下丘脑和脊髓发出投射。这些神经元会受到各种药物的药理作用影响。肾上腺素神经元系统可能在单胺氧化酶抑制剂、摄取抑制剂以及α和β激动剂与拮抗剂的某些药理作用中发挥作用。PNMT抑制剂目前是在不改变脑中去甲肾上腺素或多巴胺神经元的情况下,从药理学角度改变肾上腺素能神经元的唯一手段。对影响肾上腺素能神经元的药物进行持续研究,有助于阐明这些神经元的功能。影响肾上腺素能神经元的药物可能用于治疗高血压、精神疾病、神经内分泌功能障碍以及其他可能的疾病。